Apalutamide
The serum concentration of Lamivudine can be decreased when it is combined with Apalutamide.
Bupropion
The serum concentration of Lamivudine can be increased when it is combined with Bupropion.
Eltrombopag
The serum concentration of Lamivudine can be increased when it is combined with Eltrombopag.
Emtricitabine
The risk or severity of adverse effects can be increased when Lamivudine is combined with Emtricitabine.
Ganciclovir
The risk or severity of adverse effects can be increased when Ganciclovir is combined with Lamivudine.
Isavuconazole
The serum concentration of Lamivudine can be increased when it is combined with Isavuconazole.
Lumacaftor
The serum concentration of Lamivudine can be decreased when it is combined with Lumacaftor.
Ranolazine
The serum concentration of Lamivudine can be increased when it is combined with Ranolazine.
Ribavirin
Ribavirin may increase the hepatotoxic activities of Lamivudine.
Rolapitant
The serum concentration of Lamivudine can be increased when it is combined with Rolapitant.
Teriflunomide
The serum concentration of Lamivudine can be increased when it is combined with Teriflunomide.
Tipiracil
The serum concentration of Tipiracil can be increased when it is combined with Lamivudine.
Trimethoprim
Trimethoprim may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Valganciclovir
The risk or severity of adverse effects can be increased when Valganciclovir is combined with Lamivudine.
Vemurafenib
The serum concentration of Lamivudine can be increased when it is combined with Vemurafenib.
MEDINDIA
Email













